LYMPHOCYTIC LEUKEMIA, CHRONIC
Clinical trials for LYMPHOCYTIC LEUKEMIA, CHRONIC explained in plain language.
Never miss a new study
Get alerted when new LYMPHOCYTIC LEUKEMIA, CHRONIC trials appear
Sign up with your email to follow new studies for LYMPHOCYTIC LEUKEMIA, CHRONIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Hard-to-Treat blood cancers: experimental drug combo shows promise
Disease control CompletedThis study tested an experimental drug called mosunetuzumab, given alone or with another drug (atezolizumab), in 713 people with B-cell non-Hodgkin lymphoma or chronic lymphocytic leukemia that had come back or stopped responding to prior treatments. The goal was to find the safe…
Matched conditions: LYMPHOCYTIC LEUKEMIA, CHRONIC
Phase: PHASE1, PHASE2 • Sponsor: Genentech, Inc. • Aim: Disease control
Last updated May 26, 2026 12:02 UTC
-
New combo shows promise in CLL battle for patients with additional health issues
Disease control CompletedThis study tested a new combination of two drugs (obinutuzumab and venetoclax) against a standard combination (obinutuzumab and chlorambucil) in 445 people with untreated chronic lymphocytic leukemia (CLL) who also had other medical conditions. The main goal was to see which comb…
Matched conditions: LYMPHOCYTIC LEUKEMIA, CHRONIC
Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated May 26, 2026 12:00 UTC